v3.25.1
CONDENSED BALANCE SHEETS (Unaudited) - USD ($)
Mar. 31, 2025
Dec. 31, 2024
Current assets:    
Cash $ 11,023 $ 34,044
Total current assets 11,023 34,044
Deferred offering costs associated with proposed public offering 567,505 400,000
Total Assets 578,528 434,044
Current liabilities:    
Accounts payable 570,544 563,291
Accrued expenses 400,000 400,000
Note payable - related party 189,202 34,043
Total current liabilities 1,159,746 997,334
Total Liabilities 1,159,746 997,334
Shareholders’ Deficit    
Preference shares, $0.0001 par value; 5,000,000 shares authorized; none issued or outstanding
Ordinary shares, $0.0001 par value; 550,000,000 shares authorized; 7,503,750 shares issued and outstanding [1],[2] 750 750
Additional paid-in capital 174,250 174,250
Accumulated deficit (756,218) (738,290)
Total shareholders’ deficit (581,218) (563,290)
Total Liabilities and Shareholders’ Deficit $ 578,528 $ 434,044
[1] On April 29, 2025, the Company capitalized US$31.63 standing to the credit of the Company’s share premium account and issued an additional 316,250 founder shares, resulting in an increase in the total number of ordinary shares outstanding from 7,187,500 to 7,503,750. All shares and associated amounts have been retroactively restated to reflect the share capitalization (see Note 5).
[2] This number includes up to 978,750 ordinary shares subject to forfeiture if the over-allotment option was not exercised in full or in part by the underwriters.